A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.

Although geometric mean C avg confidence intervals were substantially wider among both age groups due to limitations in sample size ( Table 2 ), there is an apparent trend of lower C avg among the younger age group (AG2, 2 to <7 years).

also in 709 other papers